Senior officials from the FDA and NIA joined advocates and researchers to discuss collaborations for advancing Alzheimer's disease knowledge into clinical trials. The meeting aimed to identify reliable biomarkers and symptomatic approaches to improve treatment of major behavioral and psychiatric aspects of the disease.
The Alliance will develop a nationwide cohort of advocates with expertise in PCOR/CER to address under-representation of older adults and caregivers. The project aims to improve informed health care decisions and increase the usefulness of PCORI's information.
A national survey found that over half of Americans know of heart valve disease but less than a quarter understand its symptoms. The condition affects over five million people and can be serious, highlighting the need for increased awareness and education.
The Alliance for Aging Research released a white paper highlighting the factors driving low vaccination rates among seniors and offering recommendations for improvement. Vaccination rates are lower than target levels set by Healthy People 2020, resulting in significant health issues and deaths among older adults.
The American Aging Association Meeting presented new findings on the role of mTor in aging, as well as insights into the impact of circadian rhythms on lifespan. Researchers also explored the potential of the FAT10 gene and its role in aging research.
The report, endorsed by national not-for-profit research organizations, urges a 10% increase in the NIH budget to address Alzheimer's, diabetes, and arthritis. This investment could lead to major medical advances and alleviate suffering from aging-related diseases.